MedPath

Cefuroxime

Generic Name
Cefuroxime
Brand Names
Ceftin
Drug Type
Small Molecule
Chemical Formula
C16H16N4O8S
CAS Number
55268-75-2
Unique Ingredient Identifier
O1R9FJ93ED
Background

Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.

Indication

For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.

Associated Conditions
Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB), Animal bite, Bacterial Infections, Bone and Joint Infections, Impetigo, Lower Respiratory Tract Infection (LRTI), Lyme Disease, Maxillary Sinusitis, Meningitis, Neisseria Gonorrhoeae Infection, Septicemia, Skin and Subcutaneous Tissue Bacterial Infections, Urinary Tract Infection, Bacterial otitis media, Mild Streptococcal pharyngitis, Mild Streptococcal tonsillitis, Moderate Streptococcal pharyngitis, Moderate Streptococcal tonsillitis

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

Phase 4
Recruiting
Conditions
Cystectomy
Bladder Cancer Requiring Cystectomy
Postoperative Infections
Antibiotic Prophylaxis
Ileal Conduit
Interventions
First Posted Date
2024-11-29
Last Posted Date
2025-01-09
Lead Sponsor
Rigshospitalet, Denmark
Target Recruit Count
248
Registration Number
NCT06709196
Locations
🇩🇰

Department of Urology, Aalborg University Hospital, Aalborg, Denmark

🇩🇰

Department of Urology, Aarhus University Hospital, Aarhus, Denmark

🇩🇰

Department of Urology, Rigshospitalet, Copenhagen, Denmark

and more 2 locations

Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women With Pyelonephritis

Phase 4
Not yet recruiting
Conditions
Pyelonephritis in Pregnancy
Interventions
First Posted Date
2024-07-30
Last Posted Date
2024-07-30
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Target Recruit Count
100
Registration Number
NCT06527560
Locations
🇧🇷

HCPA, Porto Alegre, RS, Brazil

Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin

First Posted Date
2024-04-08
Last Posted Date
2024-04-08
Lead Sponsor
Qilu Hospital of Shandong University
Target Recruit Count
248
Registration Number
NCT06351891
Locations
🇨🇳

Qilu Hospital of Shandong University, Jinan, Shandong, China

Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)

Phase 4
Recruiting
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2023-03-24
Last Posted Date
2024-10-21
Lead Sponsor
Leiden University Medical Center
Target Recruit Count
344
Registration Number
NCT05784311
Locations
🇳🇱

Leiden University Medical Center, Leiden, Zuid Holland, Netherlands

🇳🇱

Amsterdam University Medical Center, Amsterdam, Netherlands

🇳🇱

Amphia Ziekenhuis, Breda, Netherlands

and more 8 locations

Colo-Pro_2: Bolus-continuous Infusion Cefuroxime Prophylaxis for the Prevention of Infections After Colorectal Surgery

Phase 2
Recruiting
Conditions
Antibiotic Prophylaxis
Colorectal Surgery
Interventions
First Posted Date
2022-11-08
Last Posted Date
2024-05-08
Lead Sponsor
University of Leeds
Target Recruit Count
180
Registration Number
NCT05609240
Locations
🇬🇧

TheUniversity of Birmingham, Birmingham, West Midlands, United Kingdom

🇬🇧

Aneurin Bevan University Health Board, Newport, United Kingdom

🇬🇧

Leeds Teaching Hospitals, Leeds, West Yorkshire, United Kingdom

Does Antibiotic Prophylaxis at Urinary Catheter Removal Prevent Urinary Tract Infections

Not Applicable
Conditions
Urologic Diseases
Urinary Tract Disease
Interventions
First Posted Date
2022-10-13
Last Posted Date
2022-10-13
Lead Sponsor
Omri Schwarztuch Gildor
Target Recruit Count
1000
Registration Number
NCT05577273
Locations
🇮🇱

Meir Medical Center, Kfar-Sava, Israel

Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery

Phase 2
Completed
Conditions
Antibiotics Prophylaxis
Surgical Site Infection
Interventions
First Posted Date
2022-05-31
Last Posted Date
2023-05-26
Lead Sponsor
Dr. Promise Tamunoipiriala Jaja
Target Recruit Count
96
Registration Number
NCT05398081
Locations
🇳🇬

University College Hospital, Ibadan, Oyo, Nigeria

Population Pharmacokinetics, Effectiveness and Safety of Cefuroxime in Neonates

Recruiting
Conditions
Infectious Disease
First Posted Date
2022-05-24
Last Posted Date
2022-05-24
Lead Sponsor
Shandong University
Target Recruit Count
100
Registration Number
NCT05388747
Locations
🇨🇳

Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, Tianjin, China

Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment

Not Applicable
Suspended
Conditions
Helicobacter Pylori Infection
Interventions
Drug: Classic bismuth quadruple treatment
First Posted Date
2021-01-25
Last Posted Date
2022-11-14
Lead Sponsor
Shanghai East Hospital
Target Recruit Count
82
Registration Number
NCT04723472
Locations
🇨🇳

Shanghai East Hospital, Shanghai, Shanghai, China

Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection

Early Phase 1
Recruiting
Conditions
Bacterial Infection
Upper Respiratory Tract Infection
Chinese Medicine
Pediatric Acute Upper Respiratory Tract Infection
Interventions
Drug: QingFei Granule
First Posted Date
2020-07-21
Last Posted Date
2022-11-15
Lead Sponsor
Zhong Wang
Target Recruit Count
60
Registration Number
NCT04479657
Locations
🇨🇳

Dongfang Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath